Typhax

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameTyphax
Drug Alias Name伤寒疫苗Typhoid Vaccinetyphoid fever PCMV candidate伤寒沙门氏菌多糖蛋白荚膜基质疫苗Salmonella Typhi Vi polysaccharide protein capsular matrix vaccine
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Biological material > Bacterial vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsTyphoid Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesMatrivax Research & Development Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMatrivax Research & Development Corp
Active IndicationsN/A
Inactive IndicationsTyphoid Fever

Other Information

ATC CodeN/A
Related LinksN/A